Author

Federico Bolognani

APRAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IMPROVES WET WEIGHT ABSORPTION IN SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE (SBS-IF) AND COLON-IN-CONTINUITY (CIC)
APRAGLUTIDE, A NOVEL LONG-ACTING GLP-2 ANALOG, IMPROVES WET WEIGHT ABSORPTION IN SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE (SBS-IF) AND COLON-IN-CONTINUITY (CIC)

Federico Bolognani  et al.

TRANSFERABILITY OF METABOLIC BALANCE STUDIES IN SHORT BOWEL SYNDROME: ANALYSIS OF DRY MATTER AND ENERGY CONTENTS
TRANSFERABILITY OF METABOLIC BALANCE STUDIES IN SHORT BOWEL SYNDROME: ANALYSIS OF DRY MATTER AND ENERGY CONTENTS

Federico Bolognani  et al.

THE LONG-ACTING GLP-2 ANALOG APRAGLUTIDE PROVIDES CLINICAL BENEFIT FOR PATIENTS WITH SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE AND COLON IN CONTINUITY AT 52 WEEKS
THE LONG-ACTING GLP-2 ANALOG APRAGLUTIDE PROVIDES CLINICAL BENEFIT FOR PATIENTS WITH SHORT BOWEL SYNDROME WITH INTESTINAL FAILURE AND COLON IN CONTINUITY AT 52 WEEKS

Federico Bolognani  et al.

Item 1 - 3 / 3
1